Targeted therapies: Remembrance of things past - discontinuation of second-generation TKI therapy for CML.
Cancer Theme, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, South Australia 5001, Australia.
Timothy P
TP
Hughes
Cancer Theme, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, South Australia 5001, Australia.
David M
DM
Ross
D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D047428:Protein Kinase Inhibitors
D047428:Protein Kinase Inhibitors